Authorised Prescriber Scheme for psilocybin and MDMA - Timeliness, regulatory delay, and patient access

Question

1. What is the current average processing time for applications received from psychiatrists seeking to become Authorised Prescribers of psilocybin and MDMA for treatment resistant depression and PTSD respectively? 2. Exactly how many psychiatrist applications to become authorised prescribers of psilocybin and MDMA as part of psychotherapy are currently sitting unresolved before the TGA, and why are they still unresolved?

Answer

Please see attached answer.

Documents

• Question with answer (PDF) (opens in a new tab)
• DHDA SQ26-002762.pdf (opens in a new tab)